If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,815.00    -20.00 (-0.71%)
Bid:
2,810.00
Ask:
2,815.00
Spread: 5.00 (0.178%)
Market Cap: £2.20b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

20 Sep 2024 10:57

RNS Number : 0656F
Hill & Smith PLC
20 September 2024
 

Hill & Smith PLC ('Hill & Smith' or 'the Company')

20 September 2024

Grant of Awards under the Hill & Smith 2023 Long-Term Incentive Plan ('LTIP')

On 19 September 2024 (the 'Grant Date') the Company granted an award in the form of a nil cost option over a total of 24,552 ordinary shares in the Company to Rutger Helbing, the Company's Chief Executive Officer, under the LTIP (the 'Award').

The Award will vest based on the achievement of relative Total Shareholder Return (50%) and Underlying EPS Growth (50%) performance conditions measured over a 3-year performance period. The detailed performance conditions will be provided in the 2024 Directors' Remuneration Report.

The Award will (subject to the achievement of the performance conditions) vest following the end of the performance period but will not ordinarily be exercisable until the end of a further two-year holding period.

The number of ordinary shares over which the award was granted was based on a share price of 2,046 pence per ordinary share, being the average mid-market closing share price for the three business days prior to the grant date, as derived from the London Stock Exchange daily official list.

As a result of these transactions Rutger Helbing holds share options over 24,552 ordinary shares in the Company.

 

Enquiries:

Karen Atterbury

Company Secretary

0121 704 7430

 

2024 LTIP Award

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Rutger Helbing

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

Identification code of the Financial Instrument

GB0004270301

(b)

Nature of the transaction

Grant of 2024 LTIP award (in the form of a nil-cost option to acquire ordinary shares in the Company)

(c)

Price(s) and volume(s)

Price(s)

Volume

Nil

24,552

(d)

Aggregated information:

- Aggregated volume

- Price

 

Price(s)

Volume

Nil

24,552

(e)

Date of the transaction

19 September 2024

(f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKKBPCBKKACB
Date   Source Headline
30th Apr 20257:00 amRNSDirectorate Change
11th Apr 20257:00 amRNSNotice of AGM
2nd Apr 20252:30 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSTotal Voting Rights
26th Mar 20253:50 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSBoard Appointment
24th Mar 20253:58 pmRNSTransaction in Own Shares
20th Mar 20252:06 pmRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 202512:56 pmRNSDirector/PDMR Shareholding
14th Mar 20252:28 pmRNSDirector/PDMR Shareholding
13th Mar 20251:09 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSFull Year Results
6th Mar 20257:00 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTotal Voting Rights
22nd Jan 20257:44 amRNSBlock listing Interim Review
7th Jan 20257:00 amRNSDirectorate Change
2nd Jan 20257:00 amRNSTotal Voting Rights
10th Dec 202410:06 amRNSHolding(s) in Company
2nd Dec 20247:00 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSTrading Statement
1st Nov 20247:00 amRNSTotal Voting Rights
11th Oct 20243:27 pmRNSHolding(s) in Company
11th Oct 20242:05 pmRNSDirector/PDMR Shareholding
1st Oct 20247:30 amRNSTotal Voting Rights
26th Sep 20249:00 amRNSDirector/PDMR Shareholding
20th Sep 202410:57 amRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDirectorate Changes
10th Sep 20247:00 amRNSAcquisition of Whitlow Electric
2nd Sep 20248:55 amRNSTotal Voting Rights
14th Aug 20249:56 amRNSHolding(s) in Company
8th Aug 20247:01 amRNSAcquisition of Trident Industries
8th Aug 20247:00 amRNSHalf Year Results
7th Aug 20249:06 amRNSHolding(s) in Company
1st Aug 20247:30 amRNSTotal Voting Rights
22nd Jul 202410:15 amRNSBlock listing Interim Review
1st Jul 20249:10 amRNSTotal Voting Rights
19th Jun 20248:04 amRNSDirectorate Change
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20241:39 pmRNSResult of AGM
23rd May 20247:01 amRNSAppointment of Joint Corporate Broker
23rd May 20247:00 amRNSAGM Statement
15th May 20249:25 amRNSHolding(s) in Company
1st May 20248:45 amRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20249:13 amRNSTransaction in Own Shares
26th Apr 202411:36 amRNSTransaction in Own Shares
24th Apr 202410:38 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.